Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of summary of options granted to purchase

v3.23.1
Stockholders Equity (Details) - Schedule of summary of options granted to purchase - Stock Option [Member]
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Stockholders Equity (Details) - Schedule of summary of options granted to purchase [Line Items]  
Number of Options, Outstanding at the beginning of period 4,769,441
Weighted Average Exercise Price, Outstanding at the beginning of period (in Dollars per share) | $ / shares $ 2.93
Aggregate Intrinsic Value, Outstanding at the beginning of period (in Dollars) | $ $ 40
Number of Options, Granted 1,543,000
Weighted Average Exercise Price, Granted (in Dollars per share) | $ / shares $ 0.4
Number of Options, Forfeited (197,841)
Weighted Average Exercise Price, Forfeited (in Dollars per share) | $ / shares $ 3.16
Number of Options, Exercised
Weighted Average Exercise Price, Exercised (in Dollars per share) | $ / shares
Number of Options, Outstanding at the end of period 6,114,600
Weighted Average Exercise Price, Outstanding at the end of period (in Dollars per share) | $ / shares $ 2.28
Aggregate Intrinsic Value, Outstanding at the end of period (in Dollars) | $ $ 67
Number of Options, Exercisable at end of period 2,971,229
Weighted Average Exercise Price, Exercisable at the end of period 3.08
Number of Options, Weighted average remaining contractual life of outstanding options 4 years 11 months 12 days